ESR1 and triple-negative breast carcinoma: In this case, the absence of ER and the low levels of PR, along with the relapse under an AI, pointed toward the presence of an endocrine-resistant tumor with a potential triple-negative breast cancer (TNBC)-like behavior, for which upfront CT might have been a viable therapeutic option (30–32).